Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04984733
Title Temozolomide + Nivolumab in MGMT Methylated Oesophagogastric Cancer (ELEVATE)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors University of Southampton

gastroesophageal adenocarcinoma


Nivolumab + Temozolomide

Age Groups: senior | adult
Covered Countries

Additional content available in CKB BOOST